Cited by 103HIV Research and TreatmentChromosomal and Genetic VariationsViral-associated cancers and disorders

Characterization of Human Endogenous Retroviral Elements in the Blood of HIV-1-Infected Individuals

Open access
Contreras-Galindo, Rafael, Kaplan, Mark H., Contreras-Galindo, Angie C., Gonzalez-Hernandez, Marta J., Ferlenghi, Ilaria, Giusti, Fabiola, Lorenzo, Eric, Gitlin, Scott D. +3 more·2012·Journal of Virology

Abstract

We previously reported finding the RNA of a type K human endogenous retrovirus, HERV-K (HML-2), at high titers in the plasma of HIV-1-infected and cancer patients (R. Contreras-Galindo et al., J. Virol. 82:9329–9236, 2008.). The extent to which the HERV-K (HML-2) proviruses become activated and the nature of their activated viral RNAs remain important questions. Therefore, we amplified and sequenced the full-length RNA of the env gene of the type 1 and 2 HERV-K (HML-2) viruses collected from the plasma of seven HIV-1-infected patients over a period of 1 to 3 years and from five breast cancer patients in order to reconstruct the genetic evolution of these viruses. HERV-K (HML-2) RNA was found in plasma fractions of HIV-1 patients at a density of ∼1.16 g/ml that contained both immature and correctly processed HERV-K (HML-2) proteins and virus-like particles that were recognized by anti-HERV-K (HML-2) antibodies. RNA sequences from novel HERV-K (HML-2) proviruses were discovered, including K111, which is specifically active during HIV-1 infection. Viral RNA arose from complete proviruses and proviruses devoid of a 5′ long terminal repeat, suggesting that the expression of HERV-K (HML-2) RNA in these patients may involve sense and antisense transcription. In HIV-1-infected individuals, the HERV-K (HML-2) viral RNA showed evidence of frequent recombination, accumulation of synonymous rather than nonsynonymous mutations, and conserved N-glycosylation sites, suggesting that some of the HERV-K (HML-2) viral RNAs have undergone reverse transcription and are under purifying selection. In contrast, HERV-K (HML-2) RNA sequences found in the blood of breast cancer patients showed no evidence of recombination and exhibited only sporadic viral mutations. This study suggests that HERV-K (HML-2) is active in HIV-1-infected patients, and the resulting RNA message reveals previously undiscovered HERV-K (HML-2) genomic sequences.

Integrity signals

Registry

Crossref · 10.1128/jvi.00602-11

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies have provided evidence of frequent recombination of HERV-K (HML2) proviruses and accumulation of synonymous mutations in individuals infected with HIV-1, suggesting purifying selection of HERV-K(HML2) mutants or recombinants.

    “Indeed, recent studies have provided evidence of frequent recombination of HERV-K (HML2) proviruses and accumulation of synonymous mutations in individuals infected with HIV-1, suggesting purifying selection of HERV-K(HML2) mutants or recombinants 87.”
  • Increased transcriptional levels such as observed following HIV-1 infection might be expected to favor recombination.

    “Increased transcriptional levels such as have been observed following HIV-1 infection might be expected to favor recombination 87.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Contreras-Galindo, R., Kaplan, M. H., Contreras-Galindo, A. C., Gonzalez-Hernandez, M. J., Ferlenghi, I., Giusti, F., Lorenzo, E., Gitlin, S. D., Dosik, M. H., Yamamura, Y., & Markovitz, D. M.
Affiliations
  • University of Michigan (US)
  • Stony Brook University (US)
  • Novartis (Italy) (IT)
  • Ponce Health Sciences University (PR)
Venue
Journal of Virology
Published
2012-01
Volume
86
Issue
1
Pages
262-276
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W2063547657
Cited by
103
References
2
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 6 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 9 · 2015: 14 · 2014: 13 · 2013: 11 · 2012: 6
FWCI
3.80
Type
journal article
Language
en
Open access
Locations
  • Journal of Virology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5g12rr003050-25)
  • National Cancer Institute (R01CA144043)
  • National Institute of Allergy and Infectious Diseases (R01AI062248)
  • National Center for Research Resources (G12-RR03050, G12 RR-003050)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Chromosomal and Genetic Variations
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords
HERV-K(HML-2), human endogenous retroviruses, HIV-1 infection, viral RNA, env gene, virus-like particles, breast cancer, recombination, synonymous mutations, purifying selection, N-glycosylation sites, reverse transcription, antisense transcription, long terminal repeat
MeSH terms
Humans, Molecular Sequence Data, Phylogeny, Recombination, Genetic, RNA, Viral, HIV-1, HIV Infections, Genome, Viral, Endogenous Retroviruses, Reverse Transcription, env Gene Products, Human Immunodeficiency Virus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review